Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Oxford Biodyn (OBD) Share News

123456

Oxford BioDynamics PSE test shows 94% accuracy in cancer screening

6th Feb 2023 11:28

(Alliance News) - Oxford BioDynamics PLC on Monday said its EpiSwitch blood test has demonstrated significant potential as a fast and accurate prostate cancer screening diagnostic. Read More

Oxford BioDynamics operating loss widens; EpiSwitch shows promise

24th Jan 2023 10:59

(Alliance News) - Oxford BioDynamics PLC on Tuesday said its operating loss widened and revenue remained insubstantial in the financial year that ended September 30, but it said its EpiSwitch product has received a positive response. Read More

AIM WINNERS & LOSERS: Norman Broadbent fourth quarter fee income jumps

24th Jan 2023 10:42

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday. Read More

UK earnings, trading statements calendar - next 7 days

17th Jan 2023 15:56

Read More

TRADING UPDATES: Uniphar takeover fails; Pearson notes redemption end

16th Dec 2022 21:22

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

TRADING UPDATES: Mobile Streams sees sales multiply; Corcel gets funds

25th Oct 2022 20:58

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

TRADING UPDATES: Allied Minds eyes delisting; Tertiary completes sale

7th Oct 2022 19:51

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

IN BRIEF: Oxford BioDynamics up on US reimbursement code for EpiSwitch

3rd Oct 2022 11:52

Oxford BioDynamics PLC - Oxford-based biotechnology firm focused on discovery and development of epigenetic biomarkers Says its US reimbursement code for EpiSwitch is now available. EpiSwitch Checkpoint-inhibitor Response Test is a test which predicts a patient's likely response to immune checkpoint inhibitor therapy. It was first launched in the US in February. Read More

IN BRIEF: Oxford BioDynamics wins US reimbursement code for EpiSwitch

5th Jul 2022 15:48

Oxford BioDynamics PLC - Oxford-based biotechnology firm focused on discovery and development of epigenetic biomarkers - Issued a proprietary laboratory code by the American Medical Association's Current Procedural Terminology Editorial Board. The code was issued for the EpiSwitch Checkpoint-inhibitor Response Test, a test which predicts a patient's likely response to immune checkpoint inhibitor therapy. Read More

Oxford BioDynamics shares drop as it might need funding by early 2023

28th Jun 2022 11:09

(Alliance News) - Oxford BioDynamics PLC on Tuesday said it will need additional funding - either internal or external - by early 2023, as it posted a sharp drop in half-year revenue, sending its shares tumbling. Read More

UK earnings, trading statements calendar - next 7 days

21st Jun 2022 16:04

Read More

AIM WINNERS & LOSERS: K3 Capital upbeat; Morses sinks after warning

21st Jun 2022 11:45

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday. Read More

Oxford Biodynamics shares jump as CiRT blood test available in UK

21st Jun 2022 10:47

(Alliance News) - Oxford BioDynamics PLC shares rose on Tuesday on news that the biotechnology firm's checkpoint inhibitor response test is now available in the UK. Read More

DIRECTOR DEALINGS: PCA to Bellway chair buys GBP500,000 in shares

8th Apr 2022 15:01

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Friday and not separately reported by Alliance News: Read More

DIRECTOR DEALINGS: Hyve chair and CEO buy as share price hit by Russia

3rd Mar 2022 15:26

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separately reported by Alliance News: Read More

TRADING UPDATES: Tintra faces sale delay; Seplat makes acquisition

25th Feb 2022 20:12

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

IN BRIEF: Oxford BioDynamics loss widens; says well placed for 2022

25th Jan 2022 18:06

IN BRIEF: Oxford BioDynamics loss widens; says well placed for 2022 Read More

UK earnings, trading statements calendar - next 7 days

18th Jan 2022 16:10

UK earnings, trading statements calendar - next 7 days Read More

IN BRIEF: Oxford BioDynamics Covid severity tests available in US

17th Dec 2021 20:34

IN BRIEF: Oxford BioDynamics Covid severity tests available in US Read More

DIRECTOR DEALINGS: Genus chair buys as shares sink on profit warning

24th Nov 2021 16:05

DIRECTOR DEALINGS: Genus chair buys as shares sink on profit warning Read More

123456
FTSE 100 Latest
Value8,809.74
Change53.53